Leslie Shaw to Injections, Subcutaneous
This is a "connection" page, showing publications Leslie Shaw has written about Injections, Subcutaneous.
Connection Strength
0.131
-
Bonner HS, Shaw LM. New dosing regimens for amifostine: a pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion. J Clin Pharmacol. 2002 Feb; 42(2):166-74.
Score: 0.047
-
O'Kane D, Davis L, Ardern-Jones M, Laws P, Shaw L, Cork M, Velangi S, Cooper HL, Hudson R, Smith AB, Rout R. Treatment outcomes of patients with Atopic Dermatitis (AD) treated with dupilumab through the Early Access to Medicines Scheme (EAMS) in the UK. Ulster Med J. 2021 May; 90(2):70-76.
Score: 0.045
-
Shaw LM, Bonner HS, Schuchter L, Schiller J, Lieberman R. Pharmacokinetics of amifostine: effects of dose and method of administration. Semin Oncol. 1999 Apr; 26(2 Suppl 7):34-6.
Score: 0.039